(PDF) P2.17-23 Optimal Therapy of Stage III NSCLC: The Role

P2.17-23 Optimal Therapy of Stage III NSCLC: The Role of Surgery in the Era of Immunotherapy

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1549

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

The Role of Molecular Analyses in the Era of Personalized Therapy for Advanced NSCLC

Cancer Research

Respiratory Medicine

English

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.17-23 Role of Surgery in Locoregional Advanced NSCLC; A Case of Aggressive Salvage Surgery After Definitive Chemoradiation

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.17-33 Role of Adjuvant Therapy in Pulmonary Adenosquamous Carcinoma

Journal of Thoracic Oncology

Respiratory Medicine

English

MA05.01 E6508: Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Unresectable Stage III NS-NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era

Case Reports in Oncological Medicine

English

P2.17-10 Daily Low–Dose Cisplatin and High Dose Radiotherapy for Elderly Patients With Stage III NSCLC Is Well Tolerated.

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.17-24 Does the Change in Body Mass Index During Induction Chemo/Chemoradiotherapy Affect the Outcome of Surgery in Locally Advanced NSCLC?

Journal of Thoracic Oncology

Respiratory Medicine

English

Optimisation of Chemotherapy in the Era of Immunotherapy

European Respiratory Journal

Respiratory Medicine

English